Literature DB >> 12914943

Mosaic particles formed by wild-type hepatitis B virus core protein and its deletion variants consist of both homo- and heterodimers.

Andris Kazaks1, Andris Dishlers, Paul Pumpens, Rainer Ulrich, Detlev H Krüger, Helga Meisel.   

Abstract

Co-expression in Escherichia coli of wild-type (wt) hepatitis B virus core protein (HBc) and its naturally occurring variants with deletions at amino acid positions 77-93 or 86-93 leads to formation of mosaic particles, which consist of three dimer subunit compositions. These compositions are wt/variant HBc heterodimers and two types of homodimers, formed by wt HBc or the variant HBc themselves. Mosaic particles were found also when both HBc deletion variants 77-93 and 86-93 were co-expressed in E. coli. These findings are discussed in terms of their significance for hepatitis B virus pathogenesis and prospective use of mosaic particles in vaccine development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914943     DOI: 10.1016/s0014-5793(03)00805-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs.

Authors:  Tong-Dong Shi; Yu-Zhang Wu; Zheng-Cai Jia; Li-Yun Zou; Wei Zhou
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

2.  Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein.

Authors:  Indulis Cielens; Ludmila Jackevica; Arnis Strods; Andris Kazaks; Velta Ose; Janis Bogans; Paul Pumpens; Regina Renhofa
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.860

3.  HBV polymerase overexpression due to large core gene deletion enhances hepatoma cell growth by binding inhibition of microRNA-100.

Authors:  Ya-Hui Huang; Ying-Hsin Tseng; Wey-Ran Lin; George Hung; Tse-Ching Chen; Tong-Hong Wang; Wei-Chen Lee; Chau-Ting Yeh
Journal:  Oncotarget       Date:  2016-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.